FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

32647211000001106: Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-May 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
99647301000001119 Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
99647401000001110 Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) Is a Betahistine 16mg tablets true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) Is a Betahistine 16mg tablets false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) Is a Product containing precisely betahistine 16 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) Has active ingredient Betahistine false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) Has specific active ingredient Betahistine dihydrochloride true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) 84 tablet 7 x 12 tablets Has AMP True Betahistine 16mg tablets (Genesis Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start